What question did this study set out to answer?

This review aims to identify and evaluate biomarkers that assist in the early diagnosis of traumatic lung injury (TLI) and assess its severity.

March 24, 2026Open Access

Biomarkers in Traumatic Lung Injury - A Systematic Review

Key Points

This review aims to identify and evaluate biomarkers that assist in the early diagnosis of traumatic lung injury (TLI) and assess its severity.
Conducted a systematic review of existing literature on biomarkers for TLI.
Included studies that focus on CC16, sRAGE, and angiopoietin 2.
Analyzed the prognostic potential of identified biomarkers.
CC16, sRAGE, and angiopoietin 2 are highlighted as the most promising biomarkers.
These biomarkers are suggested as valuable tools for early diagnosis and severity stratification of TLI.

Abstract

Biomarkers show promise for early TLI diagnosis and stratification. CC16, sRAGE, and angiopoietin 2 emerge as the most promising biomarkers for prognosticating the severity of TLI.

Read Full Paperexternally

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Åhs et al. (Fri,) studied this question.

synapsesocial.com/papers/69c2294caeb5a845df0d382c https://doi.org/https://doi.org/10.1016/j.jss.2026.02.018

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Perguntar à IA

Bookmark

View Full Paper